{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:25:17Z","timestamp":1791181517883,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Follicular lymphoma is a monoclonal B-cell malignancy with each patient's tumor expressing a unique cell surface immunoglobulin (Ig), or B-cell receptor (BCR), that can potentially recognize antigens and\/or transduce signals into the tumor cell. Here we evaluated the reactivity of tumor derived Igs for human tissue antigens. Self-reactivity was observed in 26% of tumor Igs (25 of 98). For one follicular lymphoma patient, the recognized self-antigen was identified as myoferlin. This patient's tumor cells bound recombinant myoferlin in proportion to their level of BCR expression, and the binding to myoferlin was preserved despite ongoing somatic hypermutation of Ig variable regions. Furthermore, BCR-mediated signaling was induced after culture of tumor cells with myoferlin. These results suggest that antigen stimulation may provide survival signals to tumor cells and that there is a selective pressure to preserve antigen recognition as the tumor evolves.<\/jats:p>","DOI":"10.1182\/blood-2012-05-427534","type":"journal-article","created":{"date-parts":[[2012,9,30]],"date-time":"2012-09-30T22:09:38Z","timestamp":1349042978000},"page":"4182-4190","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":89,"title":["Self-antigen recognition by follicular lymphoma B-cell receptors"],"prefix":"10.1182","volume":"120","author":[{"given":"Kacey L.","family":"Sachen","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Strohman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stanford University School of Medicine, Stanford, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Singletary","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ash A.","family":"Alizadeh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole H.","family":"Kattah","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Immunology and Rheumatology, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lossos","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth D.","family":"Mellins","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stanford University School of Medicine, Stanford, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana","family":"Levy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Levy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111808463865600_B1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1200\/JCO.2001.19.2.420","article-title":"Frequency of the Bcl-2\/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma.","volume":"19","author":"Summers","year":"2001","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111808463865600_B2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.leukres.2005.10.001","article-title":"The bcl-2\/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.","volume":"30","author":"Schmitt","year":"2006","journal-title":"Leuk Res"},{"issue":"4","key":"2019111808463865600_B3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/ijc.23958","article-title":"Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals.","volume":"124","author":"Sch\u00fcler","year":"2009","journal-title":"Int J Cancer"},{"issue":"26","key":"2019111808463865600_B4","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1200\/JCO.2005.26.856","article-title":"Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors.","volume":"23","author":"de Jong","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019111808463865600_B5","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.leu.2403844","article-title":"Clonal selection in the bone marrow involvement of follicular lymphoma.","volume":"19","author":"Bogn\u00e1r","year":"2005","journal-title":"Leukemia"},{"issue":"1","key":"2019111808463865600_B6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0092-8674(86)90488-5","article-title":"Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B-cell lymphoma.","volume":"44","author":"Cleary","year":"1986","journal-title":"Cell"},{"issue":"10","key":"2019111808463865600_B7","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.4049\/jimmunol.176.10.5715","article-title":"Cutting edge: constitutive B cell receptor signaling is critical for basal growth of B lymphoma.","volume":"176","author":"Gururajan","year":"2006","journal-title":"J Immunol"},{"issue":"4","key":"2019111808463865600_B8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri1808","article-title":"ITAM-mediated tonic signalling through pre-BCR and BCR complexes.","volume":"6","author":"Monroe","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2019111808463865600_B9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0952-7915(00)00206-5","article-title":"Towards an understanding of somatic hypermutation.","volume":"13","author":"Jacobs","year":"2001","journal-title":"Curr Opin Immunol"},{"issue":"15","key":"2019111808463865600_B10","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1073\/pnas.89.15.6770","article-title":"Clonal evolution of a follicular lymphoma: evidence for antigen selection.","volume":"89","author":"Bahler","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111808463865600_B11","first-page":"5547S","article-title":"Antigen selection in human lymphomagenesis.","volume":"52","author":"Bahler","year":"1992","journal-title":"Cancer Res"},{"issue":"5","key":"2019111808463865600_B12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/intimm\/dxn026","article-title":"Improved methods for detecting selection by mutation analysis of Ig V region sequences.","volume":"20","author":"Hershberg","year":"2008","journal-title":"Int Immunol"},{"issue":"11","key":"2019111808463865600_B13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/intimm\/dxq441","article-title":"Ig gene diversification and selection in follicular lymphoma, diffuse large B-cell lymphoma and primary central nervous system lymphoma revealed by lineage tree and mutation analyses.","volume":"22","author":"Zuckerman","year":"2010","journal-title":"Int Immunol"},{"issue":"13","key":"2019111808463865600_B14","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood.V98.13.3745","article-title":"The B-cell receptor of a hepatitis C virus (HCV)\u2013associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis.","volume":"98","author":"Quinn","year":"2001","journal-title":"Blood"},{"issue":"2","key":"2019111808463865600_B15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111808463865600_B16","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.20050068","article-title":"Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity.","volume":"201","author":"Bende","year":"2005","journal-title":"J Exp Med"},{"issue":"3","key":"2019111808463865600_B17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood-2009-06-228015","article-title":"Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins.","volume":"115","author":"Craig","year":"2010","journal-title":"Blood"},{"issue":"12","key":"2019111808463865600_B18","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1182\/blood-2011-03-341651","article-title":"Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity.","volume":"118","author":"Warsame","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111808463865600_B19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/leu.2009.186","article-title":"A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence.","volume":"24","author":"Darzentas","year":"2010","journal-title":"Leukemia"},{"issue":"6","key":"2019111808463865600_B20","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1172\/JCI24387","article-title":"Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.","volume":"115","author":"Herv\u00e9","year":"2005","journal-title":"J Clin Invest"},{"issue":"13","key":"2019111808463865600_B21","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1182\/blood-2008-06-162024","article-title":"Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.","volume":"112","author":"Chu","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2019111808463865600_B22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1365-2141.1999.01732.x","article-title":"The genetic variability of the VH genes in follicular lymphoma: the impact of the hypermutation mechanism.","volume":"107","author":"Noppe","year":"1999","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111808463865600_B23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood.V78.3.581.581","article-title":"Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas.","volume":"78","author":"Dighiero","year":"1991","journal-title":"Blood"},{"issue":"1","key":"2019111808463865600_B24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10428190802563355","article-title":"Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma.","volume":"50","author":"Timmerman","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"2019111808463865600_B25","first-page":"LB-204","article-title":"Results of a phase 3 trial evaluating safety and efficacy of specific immunotherapy, recombinant idiotype (Id) conjugated to KLH (Id-KLH) with GM-CSF, compared to non-specific immunotherapy, KLH with GM-CSF, in patients with follicular non-Hodgkin's lymphoma (fNHL) [abstract].","author":"Levy","year":"2008","journal-title":"AACR Meeting Abstracts"},{"issue":"2","key":"2019111808463865600_B26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0161-5890(92)90100-C","article-title":"Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire.","volume":"29","author":"Campbell","year":"1992","journal-title":"Mol Immunol"},{"key":"2019111808463865600_B27","doi-asserted-by":"crossref","first-page":"W499","DOI":"10.1093\/nar\/gkr413","article-title":"Detecting selection in immunoglobulin sequences.","volume":"39","author":"Uduman","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"42","key":"2019111808463865600_B28","doi-asserted-by":"crossref","first-page":"30745","DOI":"10.1074\/jbc.M704798200","article-title":"Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function.","volume":"282","author":"Bernatchez","year":"2007","journal-title":"J Biol Chem"},{"issue":"1","key":"2019111808463865600_B29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00216-006-0528-9","article-title":"Determination of ceruloplasmin in human serum by SEC-ICPMS.","volume":"386","author":"Lopez-Avila","year":"2006","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"2019111808463865600_B30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ab.2008.03.035","article-title":"Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet.","volume":"377","author":"Abdiche","year":"2008","journal-title":"Anal Biochem"},{"key":"2019111808463865600_B31","doi-asserted-by":"crossref","DOI":"10.1002\/0471142956.cy1017s53","article-title":"Web-based analysis and publication of flow cytometry experiments.","author":"Kotecha","year":"2010","journal-title":"Curr Protoc Cytom"},{"issue":"6","key":"2019111808463865600_B32","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jcp.53.6.424","article-title":"The use of laboratory tests in the diagnosis of SLE.","volume":"53","author":"Egner","year":"2000","journal-title":"J Clin Pathol"},{"issue":"2","key":"2019111808463865600_B33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.immuni.2007.01.009","article-title":"Autoreactivity in human IgG+ memory B cells.","volume":"26","author":"Tiller","year":"2007","journal-title":"Immunity"},{"issue":"2","key":"2019111808463865600_B34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.20052033","article-title":"A checkpoint for autoreactivity in human IgM+ memory B cell development.","volume":"203","author":"Tsuiji","year":"2006","journal-title":"J Exp Med"},{"issue":"7","key":"2019111808463865600_B35","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood.V99.7.2562","article-title":"Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma.","volume":"99","author":"Zhu","year":"2002","journal-title":"Blood"},{"issue":"10","key":"2019111808463865600_B36","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1074\/jbc.M602690200","article-title":"Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor.","volume":"282","author":"Radcliffe","year":"2007","journal-title":"J Biol Chem"},{"issue":"6873","key":"2019111808463865600_B37","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nature714","article-title":"Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas.","volume":"415","author":"Martin","year":"2002","journal-title":"Nature"},{"issue":"9","key":"2019111808463865600_B38","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1182\/blood-2006-02-003921","article-title":"Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells.","volume":"108","author":"Irish","year":"2006","journal-title":"Blood"},{"key":"2019111808463865600_B39","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood.V14.10.1151.1151","article-title":"Leukemia and auto-immunization: some possible relationships.","volume":"14","author":"Dameshek","year":"1959","journal-title":"Blood"},{"issue":"4","key":"2019111808463865600_B40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaut.2010.07.004","article-title":"Somatic hypermutation and antigen-driven selection of B cells are altered in autoimmune diseases.","volume":"35","author":"Zuckerman","year":"2010","journal-title":"J Autoimmun"},{"issue":"4","key":"2019111808463865600_B41","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/eji.200939914","article-title":"Ectopic GC in the thymus of myasthenia gravis patients show characteristics of normal GC.","volume":"40","author":"Zuckerman","year":"2010","journal-title":"Eur J Immunol"},{"issue":"5","key":"2019111808463865600_B42","first-page":"596","article-title":"Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.","volume":"91","author":"Willenbrock","year":"2006","journal-title":"Haematologica"},{"issue":"5","key":"2019111808463865600_B43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.20042251","article-title":"Defective B cell tolerance checkpoints in systemic lupus erythematosus.","volume":"201","author":"Yurasov","year":"2005","journal-title":"J Exp Med"},{"issue":"4","key":"2019111808463865600_B44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1084\/jem.188.4.765","article-title":"Antigen receptor engagement turns off the V(D)J recombination machinery in human tonsil B cells.","volume":"188","author":"Meffre","year":"1998","journal-title":"J Exp Med"},{"issue":"10","key":"2019111808463865600_B45","first-page":"2537","article-title":"Clonal evolution of t(14;18) follicular lymphomas demonstrated by immunoglobulin genes and the 18q21 major breakpoint region.","volume":"47","author":"Raffeld","year":"1987","journal-title":"Cancer Res"},{"issue":"5","key":"2019111808463865600_B46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/10428199409073774","article-title":"Immunoglobulin somatic variation: studies of receptor editing in a human B-cell lymphoma.","volume":"12","author":"Stiernholm","year":"1994","journal-title":"Leuk Lymphoma"},{"issue":"19","key":"2019111808463865600_B47","doi-asserted-by":"crossref","first-page":"14056","DOI":"10.1074\/jbc.M700906200","article-title":"RAS\/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation.","volume":"282","author":"Roux","year":"2007","journal-title":"J Biol Chem"},{"issue":"43","key":"2019111808463865600_B48","doi-asserted-by":"crossref","first-page":"18587","DOI":"10.1073\/pnas.1009388107","article-title":"Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins.","volume":"107","author":"Coelho","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2019111808463865600_B49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.beha.2011.03.006","article-title":"New agents in follicular lymphoma.","volume":"24","author":"Cheson","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"2019111808463865600_B50","first-page":"280","article-title":"New therapeutic targets and drugs in non-Hodgkin's lymphoma.","volume":"18","author":"Sawas","year":"2011","journal-title":"Curr Opin Hematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/20\/4182\/1359919\/zh804612004182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/20\/4182\/1359919\/zh804612004182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T09:44:34Z","timestamp":1574070274000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/20\/4182\/30563\/Selfantigen-recognition-by-follicular-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,15]]},"references-count":50,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2012,11,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-05-427534","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,15]]}}}